A neonatal agranulocytosis.

A 42-year-old gravida 5 para 3 woman delivered a male newborn at 36 weeks of gestation. She had no significant medical problems and her previous pregnancies led to healthy newborns. The current pregnancy was uneventful and the baby appeared healthy (body weight, 3190 g; Apgar score, 8/10/10). On the second day of life jaundice appeared. Laboratory tests revealed hyperbilirubinemia (total bilirubin 21.5 mg/dL; reference interval, 8.5 mg/dL), an agranulocytosis [absolute neutrophil count (ANC), 0.04 10/L; reference interval, 5–21 10/L], eosinophilia (0.83 10/L; reference interval, 0.5 10/L), and monocytosis (3.8 10/L; reference interval, 1.1 10/L). Hemoglobin (16.3 g/dL; reference interval, 14.5–22.5 g/dL), total white blood cell count (11.8 10/L; reference interval, 9.4 –34.0 10/L), and platelet count (200 10/L; reference interval, 150 –300 10/L) were within reference intervals. Microscopic examination of a May-Grünwald-Giemsa–stained blood smear confirmed agranulocytosis. There was no sign of infection. Additional testing included negative blood, gastric aspirate, and ear swab culture results and C-reactive protein concentration within the reference interval. Agranulocytosis was still present the following day (ANC, 0.064 10/L). The jaundice was felt to be due to ABO hemolytic disease of the newborn (mother O negative, newborn B negative, direct antiglobulin test positive) and was treated successfully by a 36-h regimen of phototherapy. Conversely, agranulocytosis persisted (ANC, 0.04 10/L on day 6). DISCUSSION